BioWorld MedTech

July 7, 2015

Hansen gets bump to start ARTISAN: Hansen Medical completes enrollment in initial cohort of ARTISAN clinical trial

Coming off a 5.07% bump in its shares last week, intravascular robotics specialist Hansen Medical (NASDAQ: HNSN) (Mountain View, Calif.) said it has completed enrollment in the initial evaluable cohort of its ARTISAN clinical trial. Read More

Two patents invalidated: Fed Circuit: 'Experimental' manufacturing dooms patents

Latin America: British device aker looks to ride LatAm growth

Inside the Beltway: Economic impact report makes implicit argument for repeal of device tax

Report from Europe: EU Council readies CE mark reform for 'trialogue' negotiation

Daily M&A: Vygon Group buys Preouse to upgrade vascular access

Financings: Lantheus closes initial public offering,brings in nearly $66.7 million

World in Review: Lensar moves into Indian market, establishing Sharp Sight Centers

Products

Court Report: Enzo Biochem reaches $7.1M settlement with Luminex

People in Places

Briefly noted

MDD's Cardiology Extra

Today's news in brief

BioWorld

BioWorld briefs for July 23, 2026.

To viral or not to viral: In vivo CAR T debates delivery tech

BioWorld

The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...

News in brief

BioWorld Asia

BioWorld Asia briefs for July 21, 2026

Tree in the shape of human head losing leaves

KBN-2201 reverses key features of Alzheimer’s in mice

BioWorld Science

Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.

Click chemistry drug bound to pancreatic cancer cells from mice

In vivo click ADCs could address tumor heterogeneity

BioWorld

Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...